Institutional investors hold a majority ownership of GRFS through the 61.62% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2017, these large investors purchased a net $950.8 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PICTET ASSET MANAGEMENT LTD. Bought 275.4 Thousand shares of Grifols SA
DANSKE BANK A/S (INVESTMENT MANA... Bought 22.6 Thousand shares of Grifols SA
ALLIANCEBERNSTEIN LTD. Bought 20.1 Thousand shares of Grifols SA